Assertion: compensated cirrhosis | /r/HasAspect | prior treatment
Facets:
value: with daa
type: OTHER
Source sentences:
text: Gilead Sciences announced that Japan's Ministry of Health, Labour and Welfare, or MHLW, has approved Epclusa, a once-daily treatment for adults with chronic hepatitis C virus, or HCV, infection with decompensated cirrhosis , and for patients with chronic HCV infection without cirrhosis or with compensated cirrhosis who have had prior treatment with a direct-acting antiviral therapy, or DAA.